Align TechnologyALGN
Market Cap: $16.5B
About: Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Employees: 21,805
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0% more funds holding in top 10
Funds holding in top 10: 6 [Q1] → 6 (+0) [Q2]
1.35% less ownership
Funds ownership: 87.05% [Q1] → 85.7% (-1.35%) [Q2]
6% less funds holding
Funds holding: 794 [Q1] → 745 (-49) [Q2]
17% less repeat investments, than reductions
Existing positions increased: 246 | Existing positions reduced: 297
27% less capital invested
Capital invested by funds: $21.4B [Q1] → $15.6B (-$5.84B) [Q2]
33% less call options, than puts
Call options by funds: $251M | Put options by funds: $373M
36% less first-time investments, than exits
New positions opened: 86 | Existing positions closed: 135
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
7 analyst ratings
Morgan Stanley Erin Wright 65% 1-year accuracy 15 / 23 met price target | 40%upside $310 | Overweight Maintained | 25 Jul 2024 |
Stifel Jonathan Block 50% 1-year accuracy 13 / 26 met price target | 58%upside $350 | Buy Maintained | 25 Jul 2024 |
Piper Sandler Jason Bednar 45% 1-year accuracy 18 / 40 met price target | 42%upside $315 | Overweight Maintained | 25 Jul 2024 |
Baird Jeff Johnson 58% 1-year accuracy 7 / 12 met price target | 47%upside $325 | Outperform Maintained | 22 Jul 2024 |
Piper Sandler Jason Bednar 45% 1-year accuracy 18 / 40 met price target | 49%upside $330 | Overweight Maintained | 10 Jul 2024 |
Financial journalist opinion
Based on 8 articles about ALGN published over the past 30 days